Literature DB >> 2184016

Glucose cycling is markedly enhanced in pancreatic islets of obese hyperglycemic mice.

A Khan1, V Chandramouli, C G Ostenson, P O Berggren, H Löw, B R Landau, S Efendic.   

Abstract

Pancreatic islets from fed 7-month old lean and obese hyperglycemic mice (ob/ob) were incubated with 3H2O and 5.5 mM or 16.7 mM glucose. Incorporation of 3H into the medium glucose was taken as the measure of glucose-6-P hydrolysis to glucose. Glucose utilization was measured from the yield of 3H2O from [5-3H]glucose. Only 3-4% of the glucose phosphorylated was dephosphorylated by the lean mouse islets irrespective of the glucose concentration. In contrast, the ob/ob mouse islets at 5.5 mM glucose dephosphorylated 18% of the glucose phosphorylated and 30% at 16.7 mM. Thus, the islets of hyperglycemic mice demonstrate increased glucose cycling as compared to the islets of normoglycemic lean mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184016     DOI: 10.1210/endo-126-5-2413

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Exposure of cells to a cell number-counting factor decreases the activity of glucose-6-phosphatase to decrease intracellular glucose levels in Dictyostelium discoideum.

Authors:  Wonhee Jang; Richard H Gomer
Journal:  Eukaryot Cell       Date:  2005-01

2.  Fatty acid-induced beta cell hypersensitivity to glucose. Increased phosphofructokinase activity and lowered glucose-6-phosphate content.

Authors:  Y Q Liu; K Tornheim; J L Leahy
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 3.  Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets.

Authors:  A Sjöholm
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.633

4.  Quantification of glucose cycling and the extent of equilibration of glucose 6-phosphate with fructose 6-phosphate in islets from ob/ob mice.

Authors:  V Chandramouli; A Khan; C G Ostenson; P O Berggren; H Löw; B R Landau; S E Efendić
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

5.  Moving on from GWAS: functional studies on the G6PC2 gene implicated in the regulation of fasting blood glucose.

Authors:  Richard M O'Brien
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

6.  Novel stable isotope analyses demonstrate significant rates of glucose cycling in mouse pancreatic islets.

Authors:  Martha L Wall; Lynley D Pound; Irina Trenary; Richard M O'Brien; Jamey D Young
Journal:  Diabetes       Date:  2014-12-31       Impact factor: 9.461

7.  Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction.

Authors:  Hernán Gonzalo Villagarcía; Vanesa Sabugo; María Cecilia Castro; Guillermo Schinella; Daniel Castrogiovanni; Eduardo Spinedi; María Laura Massa; Flavio Francini
Journal:  Int J Endocrinol       Date:  2016-08-11       Impact factor: 3.257

Review 8.  A detailed review on the phytochemical profiles and anti-diabetic mechanisms of Momordica charantia.

Authors:  Sunday Faith Oyelere; Oluwatobi Hezekiah Ajayi; Titilayo Eunice Ayoade; George Bueno Santana Pereira; Bolaji Charles Dayo Owoyemi; Ajibola Olaoluwa Ilesanmi; Olalekan Amos Akinyemi
Journal:  Heliyon       Date:  2022-04-06

9.  Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose.

Authors:  Xia Li; Yu-Hsiang Shu; Anny H Xiang; Enrique Trigo; Johanna Kuusisto; Jaana Hartiala; Amy J Swift; Miwa Kawakubo; Heather M Stringham; Lori L Bonnycastle; Jean M Lawrence; Markku Laakso; Hooman Allayee; Thomas A Buchanan; Richard M Watanabe
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

10.  Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.

Authors:  Wei-Min Chen; Michael R Erdos; Anne U Jackson; Richa Saxena; Serena Sanna; Kristi D Silver; Nicholas J Timpson; Torben Hansen; Marco Orrù; Maria Grazia Piras; Lori L Bonnycastle; Cristen J Willer; Valeriya Lyssenko; Haiqing Shen; Johanna Kuusisto; Shah Ebrahim; Natascia Sestu; William L Duren; Maria Cristina Spada; Heather M Stringham; Laura J Scott; Nazario Olla; Amy J Swift; Samer Najjar; Braxton D Mitchell; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Gitte Andersen; Knut Borch-Johnsen; Torben Jørgensen; Jouko Saramies; Timo T Valle; Thomas A Buchanan; Alan R Shuldiner; Edward Lakatta; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Oluf Pedersen; Antonio Cao; Leif Groop; Karen L Mohlke; Markku Laakso; David Schlessinger; Francis S Collins; David Altshuler; Gonçalo R Abecasis; Michael Boehnke; Angelo Scuteri; Richard M Watanabe
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.